Ulland Investment Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
Ulland Investment Advisors's BSX Position: Q2 2026 in Review
Ulland Investment Advisors increased its Boston Scientific (BSX) stake by 47% in Q2 2026, buying an estimated $328K and bringing the position to 18,934 shares worth $808K. The position accounts for 0.6% of the portfolio, ranked #35.
Ulland Investment Advisors first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.47M in Q1 2025. 665 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Ulland Investment Advisors held 18,934 shares of Boston Scientific worth $808K as of Q2 2026.
- Ulland Investment Advisors bought 6,045 Boston Scientific shares in Q2 2026, an estimated $328K.
- Boston Scientific made up 0.6% of Ulland Investment Advisors's portfolio in Q2 2026, its #35 holding.
- Ulland Investment Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
- Ulland Investment Advisors's Boston Scientific position peaked at $1.47M in Q1 2025.
- 665 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.